Comparison of uniportal robotic-assisted thoracic surgery pulmonary anatomic resections with multiport robotic-assisted thoracic surgery: a multicenter study of the European experience.

Uniportal robotic-assisted thoracic surgery (U-RATS) lung cancer multiport robotic-assisted thoracic surgery (M-RATS) robotic lung resections

Journal

Annals of cardiothoracic surgery
ISSN: 2225-319X
Titre abrégé: Ann Cardiothorac Surg
Pays: China
ID NLM: 101605877

Informations de publication

Date de publication:
31 Mar 2023
Historique:
received: 13 12 2022
accepted: 17 02 2023
medline: 11 4 2023
entrez: 10 4 2023
pubmed: 11 4 2023
Statut: ppublish

Résumé

Robotic-assisted thoracic surgery (RATS) has seen increasing interest in the last few years, with most procedures primarily being performed in the conventional multiport manner. Our team has developed a new approach that has the potential to convert surgeons from uniportal video-assisted thoracic surgery (VATS) or open surgery to robotic-assisted surgery, uniportal-RATS (U-RATS). We aimed to evaluate the outcomes of one single incision, uniportal robotic-assisted thoracic surgery (U-RATS) against standard multiport RATS (M-RATS) with regards to safety, feasibility, surgical technique, immediate oncological result, postoperative recovery, and 30-day follow-up morbidity and mortality. We performed a large retrospective multi-institutional review of our prospectively curated database, including 101 consecutive U-RATS procedures performed from September 2021 to October 2022, in the European centers that our main surgeon operates in. We compared these cases to 101 consecutive M-RATS cases done by our colleagues in Barcelona between 2019 to 2022. Both patient groups were similar with respect to demographics, smoking status and tumor size, but were significantly younger in the U-RATS group [M-RATS =69 (range, 39-81) years; U-RATS =63 years (range, 19-82) years; P<0.0001]. Most patients in both operative groups underwent resection of a primary non-small cell lung cancer (NSCLC) [M-RATS 96/101 (95%); U-RATS =60/101 (59%); P<0.0001]. The main type of anatomic resection was lobectomy for the multiport group, and segmentectomy for the U-RATS group. In the M-RATS group, only one anatomical segmentectomy was performed, while the U-RATS group had twenty-four (24%) segmentectomies (P=0.0006). All M-RATS and U-RATS surgical specimens had negative resection margins (R0) and contained an equivalent median number of lymph nodes available for pathologic analysis [M-RATS =11 (range, 5-54); U-RATS =15 (range, 0-41); P=0.87]. Conversion rate to thoracotomy was zero in the U-RATS group and low in M-RATS [M-RATS =2/101 (2%); U-RATS =0/101; P=0.19]. Median operative time was also statistically different [M-RATS =150 (range, 60-300) minutes; U-RATS =136 (range, 30-308) minutes; P=0.0001]. Median length of stay was significantly lower in U-RATS group at four days [M-RATS =5 (range, 2-31) days; U-RATS =4 (range, 1-18) days; P<0.0001]. Rate of complications and 30-day mortality was low in both groups. U-RATS is feasible and safe for anatomic lung resections and comparable to the multiport conventional approach regarding surgical outcomes. Given the similarity of the technique to uniportal VATS, it presents the potential to convert minimally invasive thoracic surgeons to a robotic-assisted approach.

Sections du résumé

Background UNASSIGNED
Robotic-assisted thoracic surgery (RATS) has seen increasing interest in the last few years, with most procedures primarily being performed in the conventional multiport manner. Our team has developed a new approach that has the potential to convert surgeons from uniportal video-assisted thoracic surgery (VATS) or open surgery to robotic-assisted surgery, uniportal-RATS (U-RATS). We aimed to evaluate the outcomes of one single incision, uniportal robotic-assisted thoracic surgery (U-RATS) against standard multiport RATS (M-RATS) with regards to safety, feasibility, surgical technique, immediate oncological result, postoperative recovery, and 30-day follow-up morbidity and mortality.
Methods UNASSIGNED
We performed a large retrospective multi-institutional review of our prospectively curated database, including 101 consecutive U-RATS procedures performed from September 2021 to October 2022, in the European centers that our main surgeon operates in. We compared these cases to 101 consecutive M-RATS cases done by our colleagues in Barcelona between 2019 to 2022.
Results UNASSIGNED
Both patient groups were similar with respect to demographics, smoking status and tumor size, but were significantly younger in the U-RATS group [M-RATS =69 (range, 39-81) years; U-RATS =63 years (range, 19-82) years; P<0.0001]. Most patients in both operative groups underwent resection of a primary non-small cell lung cancer (NSCLC) [M-RATS 96/101 (95%); U-RATS =60/101 (59%); P<0.0001]. The main type of anatomic resection was lobectomy for the multiport group, and segmentectomy for the U-RATS group. In the M-RATS group, only one anatomical segmentectomy was performed, while the U-RATS group had twenty-four (24%) segmentectomies (P=0.0006). All M-RATS and U-RATS surgical specimens had negative resection margins (R0) and contained an equivalent median number of lymph nodes available for pathologic analysis [M-RATS =11 (range, 5-54); U-RATS =15 (range, 0-41); P=0.87]. Conversion rate to thoracotomy was zero in the U-RATS group and low in M-RATS [M-RATS =2/101 (2%); U-RATS =0/101; P=0.19]. Median operative time was also statistically different [M-RATS =150 (range, 60-300) minutes; U-RATS =136 (range, 30-308) minutes; P=0.0001]. Median length of stay was significantly lower in U-RATS group at four days [M-RATS =5 (range, 2-31) days; U-RATS =4 (range, 1-18) days; P<0.0001]. Rate of complications and 30-day mortality was low in both groups.
Conclusions UNASSIGNED
U-RATS is feasible and safe for anatomic lung resections and comparable to the multiport conventional approach regarding surgical outcomes. Given the similarity of the technique to uniportal VATS, it presents the potential to convert minimally invasive thoracic surgeons to a robotic-assisted approach.

Identifiants

pubmed: 37035654
doi: 10.21037/acs-2022-urats-27
pii: acs-12-02-102
pmc: PMC10080339
doi:

Types de publication

Journal Article

Langues

eng

Pagination

102-109

Informations de copyright

2023 Annals of Cardiothoracic Surgery. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: The authors have no conflicts of interest to declare.

Références

Ann Cardiothorac Surg. 2023 Mar 31;12(2):130-132
pubmed: 37035649
J Thorac Dis. 2014 Oct;6(Suppl 6):S604-17
pubmed: 25379198
Eur J Cardiothorac Surg. 2022 Aug 3;62(3):
pubmed: 35951763
Front Surg. 2022 Mar 04;9:840070
pubmed: 35310438
Ann Transl Med. 2020 Jun;8(12):775
pubmed: 32647700
J Thorac Cardiovasc Surg. 2010 Nov;140(5):954
pubmed: 20951245
Transl Lung Cancer Res. 2021 Mar;10(3):1571-1575
pubmed: 33889530
J Thorac Dis. 2022 Aug;14(8):2970-2976
pubmed: 36071757
Front Surg. 2021 Feb 22;8:597416
pubmed: 33693026
Ann Surg. 2023 Mar 1;277(3):528-533
pubmed: 34534988
Front Surg. 2022 Sep 23;9:1005860
pubmed: 36329983
J Thorac Cardiovasc Surg. 2017 Sep;154(3):1065-1069
pubmed: 28623099
Ann Thorac Surg. 2012 May;93(5):1598-604; discussion 1604-5
pubmed: 22440364
J Clin Med. 2021 Apr 14;10(8):
pubmed: 33920023
Innovations (Phila). 2020 Nov/Dec;15(6):532-540
pubmed: 32988258

Auteurs

Veronica Manolache (V)

Department of Thoracic Surgery, Memorial Oncology Hospital, Bucharest, Romania.
University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.

Natalia Motas (N)

Department of Thoracic Surgery, Memorial Oncology Hospital, Bucharest, Romania.
University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.
Department of Thoracic Surgery, Institute of Oncology "Prof. Dr. Al. Trestioreanu", Bucharest, Romania.

Mugurel Liviu Bosinceanu (ML)

Department of Thoracic Surgery, Memorial Oncology Hospital, Bucharest, Romania.

Mercedes de la Torre (M)

Department of Thoracic Surgery, Coruña University Hospital, A Coruña, Spain.

Javier Gallego-Poveda (J)

Department of Cardio-Thoracic Surgery, Lusiadas Hospital, Lisbon, Portugal.

Joel Dunning (J)

Department of Cardiothoracic Surgery, James Cook University Hospital, Middlesbrough, UK.

Mahmoud Ismail (M)

Department of Thoracic Surgery, Klinikum Ernst von Bergmann Potsdam, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany.

Akif Turna (A)

Department of Thoracic Surgery, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, İstanbul, Turkey.

Marina Paradela (M)

Department of Thoracic Surgery, Coruña University Hospital, A Coruña, Spain.

Georges Decker (G)

Department of Thoracic Surgery, Hôpitaux Robert Schuman-ZithaKlinik, Luxembourg, Luxembourg.

Ricard Ramos (R)

Thoracic Surgery Service, Hospital Universitari de Bellvitge, Barcelona, Spain.

Johanes Bodner (J)

Department of Thoracic Surgery, Klinikum Bogenhausen, Englschalkinger Strasse 77, Munchen, Germany.

Dionisio Espinosa Jimenez (D)

Department of Thoracic Surgery, Hospital Puerta del Mar, Cádiz, Spain.

Patrick Zardo (P)

Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.

Alejandro Garcia-Perez (A)

Department of Thoracic Surgery, Coruña University Hospital, A Coruña, Spain.

Anna Ureña Lluveras (A)

Thoracic Surgery Service, Hospital Universitari de Bellvitge, Barcelona, Spain.

Daniel Pantile (D)

Department of Thoracic Surgery, Central Military Emergency University Hospital Bucharest, Bucharest, Romania.

Diego Gonzalez-Rivas (D)

Department of Thoracic Surgery, Memorial Oncology Hospital, Bucharest, Romania.
Department of Thoracic Surgery, Coruña University Hospital, A Coruña, Spain.
Department of Cardio-Thoracic Surgery, Lusiadas Hospital, Lisbon, Portugal.
Department of Thoracic Surgery, Klinikum Ernst von Bergmann Potsdam, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany.

Classifications MeSH